Dr Janis toboggan has two patients who were admitted to her hospital with covid-19. And she gave them both the drug known as remdesivir. Patient A got better and was released from the hospital in two days, but it took a week for patient b to recover and be sent home. That’s interesting though dr toboggan. “Why did the drug work differently in the two patients? Remedesivir seemed to help one patient but not the other. Maybe the drug speeds up recovery but the patients had different levels of infection. Or, maybe remdesvir didn’t have any effect on recovery, and the patients were just at a different places in their infections by the Novel corona virus. To find which hypothesis was a better explanation her data, Dr To boggan applies a little deductive reading. “What if I set up a situation where I have two patients at the same point in their infection and I give one the drug and one not? If remedesivir speeds up recovery, then the one with the drug will recover faster. But if remedesivir does not affect recovery, then those two patients should have similar recovery times” to get more data dr toboggan looked at 25 pairs of patients at similar points in their infections, giving one in each pair 200/mg/day of the drug and the other a placebo. Within a couple of weeks dr toboggan found that the patients that got remedesivir usually recovered 3-5 days faster than ones that didn’t. Dr toboggan concluded that the hypothesis that remedesivir has no effect on recovery was not a good explanation for her new observation. After that, she decided that all of her covid patients would benefit from being given the drug. What was the null hypothesis in dr toboggans experiment with remdesivir?
Dr Janis toboggan has two patients who were admitted to her hospital with covid-19. And she gave them both the drug known as remdesivir. Patient A got better and was released from the hospital in two days, but it took a week for patient b to recover and be sent home. That’s interesting though dr toboggan. “Why did the drug work differently in the two patients? Remedesivir seemed to help one patient but not the other. Maybe the drug speeds up recovery but the patients had different levels of infection. Or, maybe remdesvir didn’t have any effect on recovery, and the patients were just at a different places in their infections by the Novel corona virus. To find which hypothesis was a better explanation her data, Dr To boggan applies a little deductive reading. “What if I set up a situation where I have two patients at the same point in their infection and I give one the drug and one not? If remedesivir speeds up recovery, then the one with the drug will recover faster. But if remedesivir does not affect recovery, then those two patients should have similar recovery times” to get more data dr toboggan looked at 25 pairs of patients at similar points in their infections, giving one in each pair 200/mg/day of the drug and the other a placebo. Within a couple of weeks dr toboggan found that the patients that got remedesivir usually recovered 3-5 days faster than ones that didn’t. Dr toboggan concluded that the hypothesis that remedesivir has no effect on recovery was not a good explanation for her new observation. After that, she decided that all of her covid patients would benefit from being given the drug. What was the null hypothesis in dr toboggans experiment with remdesivir?
Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
Related questions
Question
Dr Janis toboggan has two patients who were admitted to her hospital with covid-19. And she gave them both the drug known as remdesivir. Patient A got better and was released from the hospital in two days, but it took a week for patient b to recover and be sent home. That’s interesting though dr toboggan. “Why did the drug work differently in the two patients? Remedesivir seemed to help one patient but not the other. Maybe the drug speeds up recovery but the patients had different levels of infection. Or, maybe remdesvir didn’t have any effect on recovery, and the patients were just at a different places in their infections by the Novel corona virus.
To find which hypothesis was a better explanation her data, Dr To boggan applies a little deductive reading. “What if I set up a situation where I have two patients at the same point in their infection and I give one the drug and one not? If remedesivir speeds up recovery, then the one with the drug will recover faster. But if remedesivir does not affect recovery, then those two patients should have similar recovery times” to get more data dr toboggan looked at 25 pairs of patients at similar points in their infections, giving one in each pair 200/mg/day of the drug and the other a placebo. Within a couple of weeks dr toboggan found that the patients that got remedesivir usually recovered 3-5 days faster than ones that didn’t. Dr toboggan concluded that the hypothesis that remedesivir has no effect on recovery was not a good explanation for her new observation. After that, she decided that all of her covid patients would benefit from being given the drug.
What was the null hypothesis in dr toboggans experiment with remdesivir?
Expert Solution
Step 1
The null hypothesis is the hypothesis which the researcher tries to disapprove or nullify whereas the alternative hypothesis is a hypothesis which the researcher tries to prove.
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education